703 related articles for article (PubMed ID: 29642941)
21. Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma.
Lee YR; Kim G; Tak WY; Jang SY; Kweon YO; Park JG; Lee HW; Han YS; Chun JM; Park SY; Hur K
Int J Cancer; 2019 Mar; 144(6):1444-1452. PubMed ID: 30338850
[TBL] [Abstract][Full Text] [Related]
22. Hepatocellular carcinoma and microRNA: new perspectives on therapeutics and diagnostics.
Yang N; Ekanem NR; Sakyi CA; Ray SD
Adv Drug Deliv Rev; 2015 Jan; 81():62-74. PubMed ID: 25450260
[TBL] [Abstract][Full Text] [Related]
23. Decreased levels of serum exosomal miR-638 predict poor prognosis in hepatocellular carcinoma.
Shi M; Jiang Y; Yang L; Yan S; Wang YG; Lu XJ
J Cell Biochem; 2018 Jun; 119(6):4711-4716. PubMed ID: 29278659
[TBL] [Abstract][Full Text] [Related]
24. Exosomes and Hepatocellular Carcinoma: From Bench to Bedside.
Sasaki R; Kanda T; Yokosuka O; Kato N; Matsuoka S; Moriyama M
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30897788
[TBL] [Abstract][Full Text] [Related]
25. Exosomal Non-Coding RNAs: New Insights into the Biology of Hepatocellular Carcinoma.
Zhang Q; Li H; Liu Y; Li J; Wu C; Tang H
Curr Oncol; 2022 Jul; 29(8):5383-5406. PubMed ID: 36005165
[TBL] [Abstract][Full Text] [Related]
26. [Exosomal proteomics study in the tumorigenesis, development and treatment of hepatocellular carcinoma].
Zhao L; Xu F; Zhang Y; Xu P
Sheng Wu Gong Cheng Xue Bao; 2020 Oct; 36(10):1992-2000. PubMed ID: 33169565
[TBL] [Abstract][Full Text] [Related]
27. Growing Evidence of Exosomal MicroRNA-Related Metastasis of Hepatocellular Carcinoma.
Sun W; Fu S; Wu S; Tu R
Biomed Res Int; 2020; 2020():4501454. PubMed ID: 33313314
[TBL] [Abstract][Full Text] [Related]
28. Exosomal miR-93 promotes proliferation and invasion in hepatocellular carcinoma by directly inhibiting TIMP2/TP53INP1/CDKN1A.
Xue X; Wang X; Zhao Y; Hu R; Qin L
Biochem Biophys Res Commun; 2018 Aug; 502(4):515-521. PubMed ID: 29859935
[TBL] [Abstract][Full Text] [Related]
29. Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis.
Zhang Z; Li X; Sun W; Yue S; Yang J; Li J; Ma B; Wang J; Yang X; Pu M; Ruan B; Zhao G; Huang Q; Wang L; Tao K; Dou K
Cancer Lett; 2017 Jul; 397():33-42. PubMed ID: 28288874
[TBL] [Abstract][Full Text] [Related]
30. Potential biomarkers in NASH-induced liver cirrhosis with hepatocellular carcinoma: A preliminary work on roles of exosomal miR-182, miR-301a, and miR-373.
Muhammad Yusuf AN; Raja Ali RA; Muhammad Nawawi KN; Mokhtar NM
Malays J Pathol; 2020 Dec; 42(3):377-384. PubMed ID: 33361718
[TBL] [Abstract][Full Text] [Related]
31. Small but Heavy Role: MicroRNAs in Hepatocellular Carcinoma Progression.
Chen E; Xu X; Liu R; Liu T
Biomed Res Int; 2018; 2018():6784607. PubMed ID: 29951542
[TBL] [Abstract][Full Text] [Related]
32. Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
Sohn W; Kim J; Kang SH; Yang SR; Cho JY; Cho HC; Shim SG; Paik YH
Exp Mol Med; 2015 Sep; 47(9):e184. PubMed ID: 26380927
[TBL] [Abstract][Full Text] [Related]
33. Exosomal miR-155 Derived from Hepatocellular Carcinoma Cells Under Hypoxia Promotes Angiogenesis in Endothelial Cells.
Matsuura Y; Wada H; Eguchi H; Gotoh K; Kobayashi S; Kinoshita M; Kubo M; Hayashi K; Iwagami Y; Yamada D; Asaoka T; Noda T; Kawamoto K; Takeda Y; Tanemura M; Umeshita K; Doki Y; Mori M
Dig Dis Sci; 2019 Mar; 64(3):792-802. PubMed ID: 30465177
[TBL] [Abstract][Full Text] [Related]
34. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
[TBL] [Abstract][Full Text] [Related]
35. Three isoforms of exosomal circPTGR1 promote hepatocellular carcinoma metastasis via the miR449a-MET pathway.
Wang G; Liu W; Zou Y; Wang G; Deng Y; Luo J; Zhang Y; Li H; Zhang Q; Yang Y; Chen G
EBioMedicine; 2019 Feb; 40():432-445. PubMed ID: 30630697
[TBL] [Abstract][Full Text] [Related]
36. Vps4A functions as a tumor suppressor by regulating the secretion and uptake of exosomal microRNAs in human hepatoma cells.
Wei JX; Lv LH; Wan YL; Cao Y; Li GL; Lin HM; Zhou R; Shang CZ; Cao J; He H; Han QF; Liu PQ; Zhou G; Min J
Hepatology; 2015 Apr; 61(4):1284-94. PubMed ID: 25503676
[TBL] [Abstract][Full Text] [Related]
37. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma.
Zhang YC; Xu Z; Zhang TF; Wang YL
World J Gastroenterol; 2015 Sep; 21(34):9853-62. PubMed ID: 26379392
[TBL] [Abstract][Full Text] [Related]
38. Exosomal miRNAs as novel cancer biomarkers: Challenges and opportunities.
Salehi M; Sharifi M
J Cell Physiol; 2018 Sep; 233(9):6370-6380. PubMed ID: 29323722
[TBL] [Abstract][Full Text] [Related]
39. Exosomal tumor-suppressive microRNAs as novel cancer therapy: "exocure" is another choice for cancer treatment.
Kosaka N; Takeshita F; Yoshioka Y; Hagiwara K; Katsuda T; Ono M; Ochiya T
Adv Drug Deliv Rev; 2013 Mar; 65(3):376-82. PubMed ID: 22841506
[TBL] [Abstract][Full Text] [Related]
40. HCC-Derived Exosomes: Critical Player and Target for Cancer Immune Escape.
Han Q; Zhao H; Jiang Y; Yin C; Zhang J
Cells; 2019 Jun; 8(6):. PubMed ID: 31181729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
